MCB Accepted Manuscript Posted Online 6 July 2015 Mol. Cell. Biol. doi:10.1128/MCB.00118-15 Copyright © 2015, American Society for Microbiology. All Rights Reserved.
1
DYNAMIC REGULATION OF AP-1 TRANSCRIPTIONAL COMPLEXES DIRECTS
2
TROPHOBLAST DIFFERENTIATION
3 4
Kaiyu Kubota§,1, Lindsey N. Kent§,2, M.A. Karim Rumi§, Katherine F. Roby¶, and
5
Michael J. Soares§,3
6 7
Institute for Reproductive Health and Regenerative Medicine, §Department of
8
Pathology and Laboratory Medicine and the ¶Department Anatomy and Cell
9
Biology, University of Kansas Medical Center, Kansas City, Kansas 66160
10 11
Submitted to: Molecular and Cellular Biology
12
Running Head: Regulation of trophoblast differentiation
13
Key Words: hemochorial placentation, AP-1, FOSL1, JUNB, trophoblast
14
differentiation
15 16
1
Supported by American Heart Association and Japan Society for the Promotion of
17
Science postdoctoral fellowships. To whom correspondence may be addressed:
18
Institute of Reproductive Health and Regenerative Medicine, Department of Pathology
19
and Laboratory Medicine, University of Kansas Medical Center, MS3050, 3901 Rainbow
20
Boulevard, Kansas City, KS, USA 66160. Tel: 1-(913)-588-5690; Fax 1-(913)-588-8287;
21
E-mail:
[email protected] 22 23
2
Present address: Department of Molecular Virology, Immunology, and Medical
24
Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA
25 26
3
To whom correspondence may be addressed: Institute of Reproductive Health and
27
Regenerative Medicine, Department of Pathology and Laboratory Medicine, University
28
of Kansas Medical Center, MS3050, 3901 Rainbow Boulevard, Kansas City, KS, USA
29
66160. Tel: 1-(913)-588-5691; Fax 1-(913)-588-8287; E-mail:
[email protected] 30 31 32
2
33 34
ABSTRACT Placentation is a process that establishes the maternal-fetal interface and is
35
required for successful pregnancy. The epithelial component of the placenta consists of
36
trophoblast cells, which possess the capacity for multi-lineage differentiation and are
37
responsible for placental-specific functions. FOS like antigen 1 (FOSL1), a component
38
of AP-1 transcription factor complexes, contributes to the regulation of placental
39
development. FOSL1 expression is restricted to trophoblast giant cells and invasive
40
trophoblast cells. In the present study, we characterized the FOSL1 regulatory pathway
41
in rat trophoblast cells. Transcriptome profiling in control and FOSL1 knockdown cells
42
identified FOSL1 dependent gene sets linked to endocrine and invasive functions.
43
FOSL1 was shown to occupy AP-1 binding sites within these gene loci, determined by
44
chromatin immunoprecipitation (ChIP). Complementary in vivo experiments using
45
trophoblast specific-lentiviral delivery of FOSL1 shRNAs provided an in vivo validation
46
of FOSL1 targets. FOSL1 actions require a dimerization partner. Co-
47
immunoprecipitation, co-immunolocalization, and ChIP analyses showed that FOSL1
48
interacts with JUNB and to a lesser extent JUN in differentiating trophoblast cells.
49
Knockdown of FOSL1 and JUNB expression inhibited both endocrine and invasive
50
properties of trophoblast cells. In summary, FOSL1 recruits JUNB to form AP-1
51
transcriptional complexes that specifically regulate the endocrine and invasive
52
trophoblast phenotype.
53
3
54 55
INTRODUCTION The placenta is a specialized tissue of pregnancy that permits development of
56
the embryo within the female reproductive tract and effectively facilitates the redirection
57
of resources from the mother to the fetus (1). Placentation is categorized based on the
58
connectivity between maternal and embryonic tissues. In hemochorial placentation, as
59
seen in rodent and most primate species, maternal blood directly bathes specialized
60
extraembryonic cells referred to as trophoblast (2). The trophoblast lineage arises early
61
in embryonic development. As the embryo grows, a subset of totipotent stem cells
62
become committed to the trophoblast cell lineage (3, 4). These cells are situated on the
63
surface of the blastocyst and are called trophectoderm. They give rise to a trophoblast
64
stem (TS) cell population initially apposed to the inner cell mass of the blastocyst and
65
expand into extraembryonic ectoderm (5-7). TS cells differentiate into multiple
66
specialized trophoblast cell types. In the rat, TS cells differentiate into syncytial
67
trophoblast cells, spongiotrophoblast cells, glycogen cells, trophoblast giant cells, and
68
invasive trophoblast cells (8, 9). Each differentiated cell type contributes to a core
69
function of the placenta. Syncytial trophoblast cells specialize in transport,
70
spongiotrophoblast and trophoblast giant cells synthesize and secrete peptide and
71
steroid hormones, glycogen cells are an energy reservoir, and invasive trophoblast cells
72
penetrate into the uterus and modify the uterine vasculature. Regulatory mechanisms
73
controlling the trophoblast lineage have been investigated (10-13).
74 75
Activator protein-1 (AP-1) consists of a family of basic leucine-zipper transcription
76
factors inducible in response to a variety of extracellular stimuli (14). The composition of
4
77
AP-1 is best characterized as heterodimers of FOS family (FOS, FOSB, FOSL1,
78
FOSL2) and JUN family (JUN, JUNB, JUND) proteins or as JUN family homodimers (15,
79
16). The AP-1 family plays an important role in the regulation of fundamental cellular
80
processes including cell proliferation, differentiation, motility, and invasion (14-16).
81
There is a remarkable specificity of the actions of AP-1, which is determined by the
82
composition of its constituent proteins (15, 16).
83 84
FOS and JUN family transcription factors are expressed in rodent and human
85
trophoblast cells (17-21) and have been implicated in the regulation of transcription of
86
an assortment of genes expressed in trophoblast cells (22-28). Mouse mutagenesis
87
has demonstrated roles for FOSL1 and JUNB in placental development (29, 30). Null
88
mutations at either Fosl1 or Junb loci result in early embryonic death. The initial
89
phenotypic descriptions suggested that FOSL1 and JUNB contributed to the regulation
90
of vascularization of the labyrinth zone of the mouse placenta (29, 20). FOSL1 is
91
prominently expressed in trophoblast giant cells and in endovascular invasive
92
trophoblast cells, placing it in a position to potentially regulate the transcription of genes
93
involved in hormone biosynthesis and in vascular remodeling, respectively (20). In rat
94
TS cells, FOSL1 expression is prominently increased during trophoblast differentiation
95
correlating with acquisition of both endocrine and invasive properties (20, 31).
96
Furthermore, FOSL1 was identified as a downstream mediator of a phosphatidylinositol
97
3-kinase/AKT signaling pathway promoting trophoblast invasion and vascular
98
remodeling (20). In vivo disruption of FOSL1 using trophoblast-specific lentiviral
99
delivery of Fosl1 shRNAs inhibited the depth of endovascular trophoblast cell invasion
5
100
(20). These actions of FOSL1 on the invasive trophoblast cell phenotype are conserved
101
in rat and human trophoblast cells (20, 21).
102 103
In this study, we delve deeper into the actions of FOSL1 on trophoblast cell
104
differentiation. Targets for FOSL1 action and FOSL1 dimerization partners are
105
identified in differentiating trophoblast cells. In vitro and in vivo research strategies were
106
performed utilizing TS cells and lentiviral trophoblast-specific gene manipulation,
107
respectively. Our experimental findings demonstrate a cooperative role for FOSL1 and
108
JUNB in regulating trophoblast cell invasive and endocrine phenotypes.
109
6
110 111
EXPERIMENTAL PROCEDURES Animals – Holtzman Sprague-Dawley rats were obtained from Harlan
112
Laboratories (Indianapolis, IN). Animals were housed in an environmentally controlled
113
facility with lights on from 0600 to 2000 h and were allowed free access to food and
114
water. The presence of a seminal plug or sperm in the vaginal smear was designated
115
day 0.5 of pregnancy. Tissues for histological analysis were frozen in dry-ice cooled
116
heptane and stored at -80°C until processed. Tissue samples for RNA or protein were
117
frozen in liquid nitrogen and stored at -80°C until processed. Female rats were made
118
pseudopregnant by mating with vasectomized males. The presence of a seminal plug
119
was designated day 0.5 of pseudopregnancy. The University of Kansas Animal Care
120
and Use Committee approved protocols for the care and use of animals.
121 122
Rcho-1 TS cells and rat blastocyst-derived TS cells – Rcho-1 TS cells were
123
maintained in stem state medium [RPMI-1640 culture medium (Life Technologies,
124
Grand Island, NY) supplemented with 20% fetal bovine serum (FBS; Sigma-Aldrich, St.
125
Louis, MO), 50 μM 2-mercaptoethanol (Sigma-Aldrich), 1 mM sodium pyruvate (Life
126
Technologies), 100 μM penicillin, and 100 U/ml streptomycin (Life Technologies)] and
127
passaged with trypsin-EDTA (Fisher, Pittsburgh, PA) (32, 33). Differentiation was
128
induced by replacing stem state medium with differentiation promoting medium [NCTC-
129
135 medium (Sigma-Aldrich) supplemented with 1% horse serum (Life technologies), 50
130
μM 2-mercaptoethanol, 1 mM sodium pyruvate, 10 mM HEPES, 4-(2-hydroxyethyl)-1-
131
piperazineethanesulfonic acid, 38 mM sodium bicarbonate, 100 μM penicillin, and 100
132
U/ml streptomycin (Fisher)]. Rat blastocyst-derived TS cells were grown in stem state
7
133
medium as described above, supplemented with fibroblast growth factor 4 (FGF4, 37.5
134
ng/ml; Sigma-Aldrich), heparin (1.5 μg/ml; Sigma-Aldrich), and rat embryonic fibroblast-
135
conditioned medium (70% of the final volume). Differentiation was induced by removal
136
of FGF4, heparin, and rat embryonic fibroblast-conditioned medium (34). Stem state
137
cells were collected within 48 h of subculture and differentiated cells were maintained
138
for 8 days in differentiation medium prior to harvesting.
139 140
Short hairpin RNA (shRNA) constructs and production of lentiviral particles
141
– Two Fosl1 shRNAs were designed and subcloned into pLKO.1 using AgeI and EcoRI
142
restriction sites (20). Jun, Junb, Jund, Grhl1 shRNAs constructs subcloned in pLKO.1
143
were obtained from Sigma-Aldrich (St. Louis, MO). A control shRNA that does not target
144
any known mammalian gene, pLKO.1-shSCR (plasmid 1864), was obtained from
145
Addgene (Cambridge, MA). Sequences representing the sense target site for each of
146
the shRNAs used in the analyses are provided in Table 1. Second-generation lentiviral
147
packaging vectors (Addgene) were used to produce lentiviral particles. Culture
148
supernatants containing lentiviral particles were harvested every 24 h for two to three
149
days, centrifuged to remove cell debris, filter sterilized, concentrated by
150
ultracentrifugation, and stored at −80°C until used. Lentiviral vector titers were
151
determined by measurement of p24 gag antigen by enzyme-linked immunosorbent
152
assay (Advanced Bioscience Laboratories, Kensington, MD).
153 154 155
In vitro lentiviral transduction – Rcho-1 TS cells and rat blastocyst-derived TS cells were exposed to lentiviral particles, selected with puromycin dihydrochloride
8
156
(Sigma-Aldrich; 2 μg/μl) for two days, and then maintained in a lower concentration of
157
the antibiotic (1 μg/μl). The puromycin selective pressure was removed during in vitro
158
differentiation.
159 160
In vivo lentiviral transduction – Rat embryos were transduced with lentiviral
161
particles as previously described (20, 35). Briefly, blastocysts collected on gestation day
162
4.5 were treated with Pronase (Sigma-Aldrich; 10 mg/ml for 10 min) to remove zonae
163
pellucidae and incubated with concentrated lentiviral particles (750 ng of p24/ml) for 4.5
164
h. Transduced blastocysts were transferred to uteri of day 3.5 pseudopregnant rats for
165
subsequent evaluation of gene knockdown and placentation site phenotypes on
166
gestation day 11.5.
167 168
DNA microarray analysis – DNA microarray analysis was performed by the
169
University of Kansas Medical Center Biotechnology Support Facility, as previously
170
described (31). Briefly, Affymetrix 230 2.0 DNA microarray chips (Affymetrix, Santa
171
Clara, CA) were probed with cDNAs generated from differentiated Rcho-1 TS cells
172
expressing control or Fosl1 shRNAs. Each experimental group was analyzed in
173
triplicate. Hybridization signals were normalized with internal controls using the MAS5
174
algorithm in the Expression Console (Affymetrix) and fold change computed. Significant
175
differences were determined by paired two-tailed Student t-tests. Microarray data was
176
processed for functional analysis using Ingenuity Pathway Analysis (Qiagen, Redwood
177
City, CA). Probe sets included in the analysis were restricted to those changing at least
9
178
two-fold between group comparisons with signal strengths of ≥ 500 for the maximal
179
value.
180 181
Quantitative reverse transcription-PCR (qRT-PCR) – RNA was extracted
182
using TRI reagent (Sigma-Aldrich) according to the manufacturer's instructions. cDNAs
183
were reverse transcribed from RNA by using cDNA synthesis reagents from Applied
184
Biosystems (Foster City, CA) according to the manufacturer's instructions. Power SYBR
185
Green PCR Master Mix (Applied Biosystems) was used in the PCR. Reactions were
186
processed using a 7500 Real-Time PCR system (Applied Biosystems). Conditions
187
included an initial holding stage (50°C for 2 min and 95°C for 10 min) and 40 cycles
188
(95°C for 15 s and 60°C for 1 min) followed by a dissociation stage (95°C for 15 s, 60°C
189
for 1 min, and then 95°C for 15 s). Primers used in the analyses are provided in Table 2.
190
The comparative cycle threshold method (ΔΔCT) was used for relative quantification of
191
the amount of mRNA normalized to 18S RNA. Values are presented relative to controls
192
for each gene.
193 194
Primary antibodies – Antibodies to FOSL1 (SC605) and JUNB (SC-8051 for all
195
applications except SC-73 was used for chromatin immunoprecipitation, ChIP) were
196
obtained from Santa Cruz Biotechnology (Santa Cruz, CA). We obtained antibodies to
197
GRHL1 (HPA005798) and pan-cytokeratin (F3418) from Sigma-Aldrich. Antibodies to
198
JUN (610326), JUND (5226-1), GAPDH (AB2302), and Histone H3 (ab1790) were
199
obtained from BD Biosciences (Franklin Lakes, NJ), Epitomics (Burlingame, CA),
200
Millipore (Billerica, MA), and Abcam (Cambridge, MA), respectively. Antibodies for
10
201
PRL3D1 and CYP11A1 were previously generated and characterized by our laboratory
202
(36, 37).
203 204
Western blotting – Whole-cell lysates were prepared in lysate buffer (Cell
205
Signaling Technology, Danvers, MA). Nuclear lysates were prepared with NE-PER
206
Nuclear Protein Extraction Kit (Thermo Fisher scientific, Rockford, IL). Lysates were
207
fractionated by SDS-PAGE. Separated proteins were electrophoretically transferred to
208
PVDF membranes. Blots were probed with the designated antibodies overnight at 4°C,
209
followed by incubation with horseradish peroxidase-conjugated secondary antibodies to
210
rabbit (Cell Signaling Technology) or mouse (Sigma-Aldrich) IgG for 1 h at room
211
temperature. Reaction products were visualized by incubation with Luminata Western
212
HRP Substrates according to the manufacturer's instructions (Millipore). Lysates from
213
293FT cells (Invitrogen, Eugene, OR) transfected with rat Jund cDNA subcloned into
214
pCMV SPORT6 (GE Healthcare, Lafayette, CO) were used as a positive control for
215
JUND immunoblots.
216 217
Immunolocalization – Ten-micrometer cryosections of placentation sites were
218
prepared and stored at −80°C until used. Tissue sections mounted on glass slides or
219
Rcho-1 TS cells plated on chamber slides were fixed in 4% paraformaldehyde, washed
220
with phosphate buffered saline (PBS), and permeabilized in PBS containing 0.25%
221
Triton X100. Following a blocking step in 10% normal goat serum for 30 min slides
222
containing the specimens were incubated with the designated primary antibodies
223
overnight at 4°C and subsequently with secondary antibodies for an additional 30 min at
11
224
room temperature. We used a secondary goat anti-rabbit antibody conjugated with
225
cyanine 3 bis-N-hydroxysuccinimide (NHS) ester (Cy3; Jackson ImmunoResearch
226
Laboratories, Inc., West Grove, PA), a secondary goat anti-rabbit antibody conjugated
227
with Alexa Fluor® 488 (Invitrogen), or a secondary goat anti-mouse antibody conjugated
228
with fluorescein isothiocyanate (FITC; Sigma-Aldrich). Nuclei were visualized with 4′,6-
229
diamidino-2-phenylindole (DAPI; Molecular Probes, Carlsbad, CA). Trophoblast cells
230
were visualized by immunostaining with pan-cytokeratin antibodies. Fluorescence
231
images were captured using a Leica DMI 4000 microscope equipped with a charged-
232
coupled device camera (Leica Microsystems GMbH, Welzlar, Germany).
233 234
Analysis of DNA content – DNA content was estimated by flow cytometry as
235
previously described (31). Cells were trypsinized and fixed in 70% ethanol and then
236
stained with propidium iodine.
237 238
Chromatin immunoprecipitation (ChIP) – ChIP analysis was performed
239
according to a previously published procedure (20). Briefly, Rcho-1 TS cells stably
240
transduced with control, Fosl1 or Junb shRNA-expressing lentiviruses were grown to
241
confluence in 150-mm dishes and differentiated for 8 days. Cells were then fixed with
242
1% formaldehyde, and purified nuclear lysates were sonicated on ice to prepare DNA
243
fragments at a size of approximately 500 bp. Lysates were immunoprecipitated with 5
244
μg of FOSL1 or JUNB antibodies and collected on protein A agarose beads (Sigma-
245
Aldrich). Rabbit IgG (BD Biosciences) was used as a nonspecific control.
246
Immunoprecipitated chromatin fragments were washed and eluted from protein A
12
247
agarose beads. DNA-protein interactions were reverse cross-linked and purified using a
248
QiaQuick PCR purification kit (Qiagen). Purified DNA fragments were characterized by
249
quantitative PCR (qPCR) using primers listed in Table 3. Putative AP-1 response
250
elements (TGAGTCA) were targeted in the ChIP analysis and identified by searching
251
specific gene loci, including 10 kbp 5’ and 3’ flanking the locus, using rVista 2.0 (38;
252
http://rvista.dcode.org/). Occupancy/enrichment was normalized to input samples by
253
use of the ΔΔCT method and presented relative to IgG controls.
254 255
Co-immunoprecipitation – Rcho-1 TS cells or rat blastocyst-derived TS cells
256
were washed with ice-cold PBS and extracted in cell lysis buffer (Epitomics). Lysates
257
were immunoprecipitated using the designated antibodies and collected on protein-A
258
agarose beads. Rabbit IgG or mouse IgG (BD Biosciences) were used as a nonspecific
259
control. Immunoprecipitated protein complexes were washed with PBS, eluted with cell
260
lysate buffer, separated by SDS-PAGE, and processed for western blot analysis using
261
the Clean blot IP detection reagent (Thermo).
262 263
Matrigel invasion assay – In vitro cellular invasive activities were measured as
264
previously described (39). Rcho-1 TS cells were differentiated for 8 days, trypsinized,
265
and placed on Transwell inserts (6.5-mm diameter, 8-μM pore; BD Biosciences) coated
266
with 400 μg/ml phenol red-free Matrigel (BD Biosciences) at a density of 3 × 104 cells
267
per insert. Cells were initially plated in stem state medium overnight and then switched
268
to differentiation medium and allowed to invade for 72 h. Invaded cells situated on the
13
269
under surface of the membrane were stained with Diff-Quik (Dade Behring, Newark,
270
DE), visualized under stereomicroscopy, and counted.
271 272
Progesterone radioimmunoassay (RIA) – Measurements of progesterone in
273
medium conditioned by Rcho-1 TS cells were performed using RIA as previously
274
reported (40). Progesterone concentrations were normalized to cellular DNA content
275
with E.Z.N.A Tissue DNA kit (Omega Bio-Tek, Norcross, GA).
276 277
Statistical analyses – Values are expressed as the mean ± the standard error of
278
the mean (SEM). All experiments were conducted at least in triplicate and were
279
replicated two to three times. Statistical comparisons between two means were
280
evaluated with Student’s t test. Analysis of variance and Tukey’s post hoc tests were
281
used in assessing differences among three or more means using GraphPad Prism
282
(GraphPad Software Inc, La Jolla, CA).
283
14
284 285
RESULTS FOSL1 and the trophoblast lineage – The hemochorial placenta consists of
286
multiple trophoblast lineages. These cell types differentiate from TS cells and include
287
trophoblast giant cells, spongiotrophoblast cells, glycogen cells, invasive trophoblast
288
cells, and syncytial trophoblast (8, 9). The activation of specific sets of genes defines
289
each lineage. Monitoring expression of Prl3d1, Tpbpa, Prl5a1, Gcm1, and Pcdh12
290
provide insights into the development of trophoblast giant cells, spongiotrophoblast cells,
291
invasive trophoblast cells, syncytial trophoblast, and glycogen trophoblast cells (32, 34,
292
41). To evaluate mechanisms of trophoblast cell differentiation, we utilized Rcho-1 TS
293
cells, which can be induced to differentiate (32).
294
Expression of FOSL1 was low in the stem state Rcho-1 TS cells, as we reported
295
previously (Fig. 1A,B; 20, 31). After differentiation, FOSL1 expression was dramatically
296
increased, localized to nuclei, and correlated with elevated expression of trophoblast
297
cell lineage specific markers, Prl3d1, Tpbpa, Prl5a1, Gcm1, and Pcdh12 (Fig. 1A; 20,
298
31). We next evaluated a role for FOSL1 in trophoblast differentiation following genetic
299
manipulation by lentiviral-transduced Fosl1 shRNAs. FOSL1 expression was efficiently
300
inhibited in the differentiated trophoblast cells expressing Fosl1 shRNAs (Fig. 1C,D,E).
301
Knockdown of FOSL1 did not adversely affect trophoblast giant cell formation but did
302
significantly decrease trophoblast giant cell DNA content (Fig. 1F). Similar effects on
303
ploidy have been observed in Rcho-1 TS cells following inhibition of phosphatidylinositol
304
3 kinase (31). Please note that Rcho-1 TS cells are tetraploid (33). Disruption of
305
FOSL1 also compromised expression of trophoblast cell differentiation-associated
306
transcripts, Prl3d1 and Prl5a1, but not Gcm1 or Pcdh12 (Fig. 1G). Tpbpa transcript
15
307
levels significantly increased following FOSL1 knockdown, suggesting that FOSL1
308
represses Tpbpa expression and/or the presence of Tpbpa-expressing trophoblast cells.
309
These findings further support the involvement of FOSL1 as a regulator of the
310
differentiation of specific trophoblast cell lineages.
311 312
FOSL1 targets in differentiating trophoblast cells – Since FOSL1 is known to
313
interact with DNA and regulate transcription we next sought to identify components of
314
the transcriptome affected by FOSL1. A DNA microarray was performed in
315
differentiated trophoblast cells under control conditions and following FOSL1
316
knockdown. The array results have been deposited in the GEO database (Accession No.
317
GSE68272; http://www.ncbi.nlm.nih.gov/geo/). Transcripts regulated by FOSL1 were
318
functionally categorized into pathways regulating specific cellular functions (Fig. 1H,
319
Tables 4, 5, 6). A subset of the FOSL1-dependent transcripts was selected for further
320
analyses by qRT-PCR. This subset of transcripts each exhibited an increase in their
321
expression during trophoblast cell differentiation and a dependence on FOSL1 (Fig.
322
2A,B). We next determined whether FOSL1 interacted with putative AP1 binding motifs
323
located in the vicinity of these target genes. FOSL1 ChIP analysis was performed in the
324
differentiated trophoblast cells and demonstrated FOSL1 occupancy at consensus AP-1
325
binding sites within these target gene loci (Fig. 2C). Collectively, these observations
326
are consistent with a role for FOSL1 in the transcriptional regulation of trophoblast
327
differentiation.
328 329
We subsequently evaluated an in vivo role for FOSL1 using a trophoblast lineage specific gene knockdown strategy (20, 35). FOSL1 was strongly expressed in nuclei of
16
330
trophoblast giant cells within the uteroplacental interface at E11.5 and significantly
331
decreased following FOSL1 knockdown (Fig. 3A,B,C), similar to our previous
332
observations (20). In vivo FOSL1 knockdown significantly attenuated the expression of
333
Prl3d1, Grhl1 and Cyp11a1 (Fig. 3D). Immunohistochemical analysis further confirmed
334
the dependence of PRL3D1 and CYP11A1 expression on FOSL1 (Fig. 3E,F).
335
Discrepancies in FOSL1 targets identified using the in vitro versus in vivo models may
336
be linked to several factors, including: i) impact of distinct environmental factors
337
emanating from the uterine decidua and/or from the embryo affecting the in vivo
338
behavior of trophoblast cells, which are absent in the cell culture; ii) the presence of
339
unique factors in the in vitro culture conditions, which are absent in the in vivo model; iii)
340
distinct compositions of trophoblast lineages in the dissected in vivo specimens versus
341
the Rcho-1 TS cell cultures.
342 343
The findings of these experiments indicate that FOSL1 targets a defined set of genes activated during trophoblast cell differentiation.
344 345
GRHL1 regulation of trophoblast cell differentiation – Among the FOSL1
346
target genes was a transcription factor, GRHL1, an evolutionarily conserved regulator of
347
epithelial cell differentiation (42, 43) and a component of the human trophoblast
348
transcriptome (44, 45). GRHL1 belongs to the mammalian GRHL transcription factor
349
family, consisting of GRHL1, GRHL2 and GRHL3 (42, 43). Expression of Grhl1 was
350
robustly upregulated during trophoblast cell differentiation, whereas Grhl2 exhibited only
351
a modest increase accompanying differentiation (Fig. 4A,B). In contrast, Grhl3 was
352
highly expressed in the stem state and expression declined following differentiation (Fig.
17
353
4A). The differentiation-dependent increase in GRHL1 expression and its dependence
354
on FOSL1 led us to evaluate a possible role for GRHL1 as a mediator of FOSL1 actions
355
on the differentiated trophoblast cell phenotype. GRHL1 expression was successfully
356
inhibited with Grhl1 shRNAs (Fig. 4C,D). Disruption of GRHL1 expression did not
357
significantly affect trophoblast cell migration through a Matrigel extracellular matrix but
358
did inhibit a subset of FOSL1 targets, Prl3d1, Cgm4, and Ppap2b (Fig. 4E,F). These
359
findings suggest that GRHL1 contributes to the downstream actions of FOSL1 on
360
trophoblast cell differentiation.
361
FOSL1 interactions with the JUN family – FOSL1 requires a dimerization
362 363
partner to regulate gene transcription (14-16). This partner is often a member of the
364
JUN family (14-16). This led to an evaluation of potential FOSL1 partners in trophoblast
365
cells. JUN and JUNB were readily detected in nuclei of differentiating trophoblast cells,
366
whereas JUND expression was below the level of sensitivity of the assay (Fig. 5A). Co-
367
immunoprecipitation experiments demonstrated that FOSL1 interacts with JUN and
368
JUNB (Fig. 5B). The relative abundance of the interacting proteins was most
369
impressive between FOSL1 and JUNB. Dual-fluorescence immunohistochemistry
370
analysis demonstrated co-localization of FOSL1 with JUN and JUNB in trophoblast cells
371
from midgestation placentation sites (Fig. 5C,D). These findings suggest that FOSL1
372
heterodimerizes with JUNB and to a lesser extent with JUN in differentiating trophoblast
373
cells.
374
18
375
JUN family regulation of trophoblast cell differentiation – Physical
376
interactions of FOSL1 with JUN family members prompted an investigation of the
377
potential involvement of each JUN family member in FOSL1 guided trophoblast cell
378
differentiation. JUN, JUND, and JUNB expression was silenced in differentiating
379
trophoblast cells using specific sets of shRNAs. FOSL1 targets were evaluated
380
following JUN family member knockdown. Expression of each JUN family member was
381
successfully inhibited using two different shRNAs (Figs. 6A,B,D,E and 7A-C). JUN
382
knockdown showed strong inhibition of Prl3d1 expression and moderate, but significant,
383
inhibition of Crispld2 and Grhl1 expression (Fig. 6C). The expression of other FOSL1
384
target genes (Cgm4, Cyp11a1, Ppap2b, and Mmp9) was not significantly affected by
385
JUN knockdown. JUND knockdown did not affect expression of any of the previously
386
identified FOSL1 target genes (Fig. 6F). In contrast, JUNB knockdown phenocopied
387
FOSL1 knockdown. Each of the FOSL1 target genes investigated was significantly
388
inhibited by JUNB knockdown (Fig. 7D). JUNB ChIP analysis further demonstrated that
389
JUNB occupancy was increased at the target gene loci (Fig. 7E). The findings mirror
390
the co-immunoprecipitation results between FOSL1 and JUN family members in
391
differentiated trophoblast cells. In summary, JUN represents a redundant contributor to
392
the activation of a subset of FOSL1 targets, whereas the evidence indicates that FOSL1
393
and JUNB fully cooperate in the regulation of gene expression during trophoblast cell
394
differentiation.
395 396 397
FOSL1 and JUNB regulation of the trophoblast phenotype – Trophoblast cells exhibit a number of specialized functions, including their capacity to invade
19
398
extracellular matrices and produce steroid hormones. Trophoblast cell invasion is
399
critical for remodeling the uterine interface (46) and steroid hormone production,
400
especially progesterone, a hormone indispensible for the maintenance of pregnancy
401
(47). In experiments shown above (Figs. 2 and 7), FOSL1 and JUNB were directly
402
linked to the regulation of expression of Mmp9, which encodes a matrix
403
metalloproteinase implicated in trophoblast cell invasion (48, 49), and Cyp11a1, which
404
encodes the rate-limiting enzyme controlling progesterone biosynthesis (50).
405
Consequently, the effects of FOSL1 and JUNB knockdown on trophoblast cell invasion
406
and progesterone production were investigated. Disruption of either FOSL1 or JUNB
407
similarly inhibited the movement of trophoblast cells through Matrigel (Fig. 8A,B), an in
408
vitro measure of their invasive potential. Additionally, knockdown of either FOSL1 or
409
JUNB inhibited trophoblast cell CYP11A1 protein concentrations and progesterone
410
production (Fig. 8C,D). Since we obtained similar phenotypes when either FOSL1 or
411
JUNB were disrupted we examined potential roles of each transcription factor on the
412
expression of its partner. FOSL1 knockdown inhibited FOSL1 expression but not JUNB,
413
whereas JUNB knockdown inhibited both JUNB and FOSL1 expression (Fig. 8E,F).
414
ChIP analysis further demonstrated that both FOSL1 and JUNB occupancy within the
415
Fosl1 gene locus (Fig. 8G). Thus FOSL1 and JUNB also contribute to a positive
416
feedback regulation of FOSL1 expression during trophoblast differentiation.
417 418
FOSL1 and JUNB partnership in blastocyst-derived rat TS cell
419
differentiation – Roles for FOSL1 and JUNB were next investigated using blastocyst-
420
derived rat TS cells (Fig. 9A-D). Blastocyst-derived rat TS cells exhibit many
20
421
similarities to Rcho-1 TS cells but also some differences, including their dependence on
422
FGF4 for proliferation and capacity for differentiation (34). Similar to Rcho-1 TS cells,
423
rat blastocyst-derived TS cells prominently expressed JUN and JUNB, whereas JUND
424
expression was below the level of detection (Fig. 9A). Additionally, FOSL1 was shown
425
to specifically interact with JUN and JUNB (Fig. 9B) as was demonstrated in Rcho-1 TS
426
cells (Fig. 4B). Each of the FOSL1 and JUNB targets identified in Rcho-1 TS cells were
427
also validated for blastocyst-derived rat TS cells (Fig. 9C,D). Some differences in the
428
expression of JUN and JUNB were noted for rat TS cells, which included differentiation-
429
dependent increases in both JUN and JUNB expression (Fig. 9A). These trophoblast
430
cell-associated JUN and JUNB expression patterns may reflect the disparate conditions
431
used to culture Rcho-1 TS cells versus rat blastocyst-derived TS cells or alternatively
432
intrinsic differences in their developmental states (34).
433
Collectively, our findings indicate that FOSL1 and JUNB cooperate to control
434
elements of trophoblast cell differentiation, including acquisition of invasive and
435
endocrine properties.
436 437
21
438 439
DISCUSSION Elucidation of signaling pathways controlling trophoblast cell differentiation is a
440
key to understanding the process of placentation. In the present study, we utilized
441
Rcho-1 TS cells, rat blastocyst-derived TS cells, and developing rat placentation sites to
442
characterize the involvement of FOSL1 and JUNB in the regulation of trophoblast cell
443
differentiation. FOSL1 and JUNB cooperate in differentiating trophoblast cells to
444
regulate target genes dictating endocrine and invasive trophoblast lineages.
445 446
The expression pattern of FOSL1 was helpful in identifying it as a candidate
447
regulator of trophoblast cell differentiation. In the TS cell stem state, FOSL1 is
448
expressed at very low levels and does not possess a recognized function. Thus, stable
449
TS cells were readily established expressing shRNAs to Fosl1. These Fosl1 shRNAs
450
effectively inhibited the differentiation-dependent upregulation of FOSL1, altering the
451
differentiated trophoblast cell transcriptome, and the ability of trophoblast cells to invade
452
extracellular matrices and produce peptide and steroid hormones. FOSL1 targets such
453
as GRHL1 may in turn regulate elements of the FOSL1-directed differentiation pathway.
454
The actions of FOSL1 could be tracked to its occupancy at regions containing AP-1
455
binding motifs for several target genes identified by transcriptome profiling. This does
456
not represent the full breadth of FOSL1 involvement in regulating the differentiated
457
trophoblast cell genome. FOSL1 can be viewed as an entry point into a regulatory
458
network controlling trophoblast cell differentiation. Identification of its genome-wide
459
binding sites via ChIP sequencing and its binding partners will provide additional insight
460
into the regulation of trophoblast cell differentiation.
22
461 462
We utilized a candidate approach to identify FOSL1 interacting proteins. FOSL1
463
is known to bind to JUN family proteins (14-16). Both JUN and JUNB were shown to
464
bind to FOSL1 and participate in some of its actions. Among the FOSL1 targets and
465
cellular responses examined in this report JUNB knockdown phenocopied FOSL1
466
knockdown. FOSL1 and JUNB have been independently implicated as regulators of
467
placental development through mouse mutagenesis experiments (29, 30). Furthermore,
468
disruption of the Ppap2b gene, a target for FOSL1 action (present study), also leads to
469
abnormalities in placentation resembling the phenotypes of the Fosl1 and Junb null
470
mouse models (51). Mutagenesis of the Jun gene results in embryonic death due to
471
liver pathologies and no overt placental abnormalities (52), implying that its role in the
472
placenta may overlap with those of other genes. JUN and JUNB exhibit an increase in
473
abundance accompanying differentiation of rat blastocyst-derived TS cells, whereas,
474
Rcho-1 TS cells express JUN and JUNB similarly in stem and differentiated states.
475
Disrupting JUN or JUNB expression in the Rcho-1 TS cell stem state slowed cell
476
proliferation, suggesting that JUN and JUNB could be acting as homodimers or
477
interacting with other JUN or FOS family members or some other protein partner(s).
478
Furthermore, the implication is that the differentiation-dependent increase in FOSL1
479
redirects JUN and JUNB to a new set of targets characteristic of the differentiated
480
trophoblast cell phenotype. JUND was not identified as a participant in the actions of
481
FOSL1. Nonetheless, JUND is a contributor to the regulation of placentation. JUND is a
482
positive regulator of glial cell missing 1 (GCM1) in developing trophoblast cells (53).
483
GCM1 is a transcription factor and is critical for development of the syncytial trophoblast
23
484
lineage and bidirectional transport of nutrients and wastes between maternal and fetal
485
compartments (54, 55). Thus, at least in part, FOSL1 and JUND expression patterns
486
are segregated and contribute to distinct interfaces – trophoblast-maternal versus
487
trophoblast-fetal, respectively. Rcho-1 TS cells and rat blastocyst-derived TS cells do
488
not readily differentiate into syncytial trophoblast (32-34), which is consistent with our
489
inability to demonstrate the involvement of JUND in the regulation of trophoblast
490
differentiation. In addition to the JUN family, FOSL1 is known to interact with several
491
other regulatory proteins (56); however, the nature of these and other potential protein
492
interactions to FOSL1 regulation of trophoblast differentiation remains to be determined.
493
In summary, FOSL1 and JUNB play a fundamental role in regulating trophoblast
494
differentiation. They exhibit overlapping expression patterns in trophoblast cells, they
495
interact with each other, and share target genes. Target genes for FOSL1 and JUNB
496
include genes encoding proteins contributing to cell motility, invasion and endocrine
497
functions of trophoblast cells. We conclude that FOSL1 recruitment of JUNB to specific
498
targets within the genome during differentiation is a key regulatory step in the
499
acquisition of trophoblast cell invasive and endocrine phenotypes.
500
24
501
ACKNOWLEDGEMENTS
502
This work was supported by the National Institutes of Health (HD020676,
503
HD079363, GM103418). We thank Dr. Dong-soo Lee and Dr. Adam Krieg (University
504
of Kansas Medical Center, Kansas City, KS) for assistance and advice with the in vivo
505
lentiviral knockdown and ChIP analyses, respectively. We also appreciate the
506
comments and advice of Dr. Michael W. Wolfe, KUMC, during various stages of this
507
project and thank Stacy McClure, Lesley Shriver, and Martin Graham for administrative
508
assistance.
509
25
510 511 512 513 514 515 516 517 518 519 520 521
REFERENCES 1. Amoroso, E.C. (1968) The evolution of viviparity. Proc. R. Soc. Med. 61, 11881200 2. Wooding, F.B.P. and Burton, G.J. (2008) Comparative Placentation – Structures, Functions, and Evolution. Springer-Verlag, Berlin, Heidelberg 3. Rossant, J. (2001) Stem cells from the mammalian blastocyst. Stem Cells 19, 477-482 4. Cockburn, K. and Rossant, J. (2010) Making the blastocyst: lessons from the mouse. J. Clin. Invest. 120, 995-1003 5. Gardner, R.L. and Beddington, R.S. (1988) Multi-lineage 'stem' cells in the mammalian embryo. J. Cell Sci. 10 (Suppl),11-27 6. Tanaka, S., Kunath, T., Hadjantonakis, A.K., Nagy, A., and Rossant, J. (1998)
522
Promotion of trophoblast stem cell proliferation by FGF4. Science 282, 2072-
523
2075
524
7. Guzman-Ayala, M., Ben-Haim, N., Beck, S., and Constam, D.B. (2004) Nodal
525
protein processing and fibroblast growth factor 4 synergize to maintain a
526
trophoblast stem cell microenvironment. Proc. Natl. Acad. Sci. USA 101, 15656-
527
15660
528
8. Soares, M.J., Chapman, B.M., Rasmussen, C.A., Dai, G., Kamei, T., and Orwig,
529
K.E. (1996) Differentiation of trophoblast endocrine cells. Placenta 17, 277-289
530
9. Soares, M.J., Chakraborty, D., Rumi, M.A.K., Konno, T., and Renaud, S.J. (2012)
531
Rat placentation: an experimental model for investigating the hemochorial
532
maternal-fetal interface. Placenta 33, 233-243
26
533 534 535 536 537 538 539 540 541 542 543 544 545 546 547
10. Simmons, D.G. and Cross, J.C. (2005) Determinants of trophoblast lineage and cell subtype specification in the mouse placenta. Dev. Biol. 284,12-24 11. Roberts, R.M. and Fisher, S.J. (2011) Trophoblast stem cells. Biol. Reprod. 84, 412-421 12. Pfeffer, P.L. and Pearton, D.J. (2012) Trophoblast development. Reproduction 143, 231-246 13. Latos, P.A. and Hemberger, M. (2014) Review: the transcriptional and signalling networks of mouse trophoblast stem cells. Placenta 35 (Suppl), S81-S85 14. Shaulian, E. and Karin, M. (2002) AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4, E131-E136 15. Hess, J., Angel, P., and Schorpp-Kistner, M. (2004) AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117, 5965-5973 16. Eferl, R. and Wagner, E.F. (2003) AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868 17. Bamberger, A.M., Bamberger, C.M., Aupers, S., Milde-Langosch, K., Löning, T.,
548
and Makrigiannakis, A. (2004) Expression pattern of the activating protein-1
549
family of transcription factors in the human placenta. Mol. Hum. Reprod. 10, 223-
550
228
551
18. Briese, J., Sudahl, S., Schulte, H.M., Löning, T., and Bamberger, A.M. (2005)
552
Expression pattern of the activating protein-1 family of transcription factors in
553
gestational trophoblastic lesions. Int. J. Gynecol. Pathol. 24, 265-270
554 555
19. Marzioni, D., Todros, T., Cardaropoli, S., Rolfo, A., Lorenzi, T., Ciarmela, P., Romagnoli, R., Paulesu, L., and Castellucci, M. (2010) Activating protein-1 family
27
556
of transcription factors in the human placenta complicated by preeclampsia with
557
and without fetal growth restriction. Placenta 31, 919-927
558
20. Kent, L. N., Rumi, M. A., Kubota, K., Lee, D. S., and Soares, M. J. (2011)
559
FOSL1 is integral to establishing the maternal-fetal interface. Mol. Cell. Biol. 31,
560
4801-4813
561
21. Renaud, S.J., Kubota, K., Rumi, M.A., and Soares, M.J. (2014) The FOS
562
transcription factor family differentially controls trophoblast migration and
563
invasion. J. Biol. Chem. 289, 5025-5039
564
22. Shida, M.M., Ng, Y.K., Soares, M.J., and Linzer, D.I. (1993) Trophoblast-specific
565
transcription from the mouse placental lactogen-I gene promoter. Mol.
566
Endocrinol. 7, 181-188
567
23. Sun, Y. and Duckworth, M.L. (1999) Identification of a placental-specific
568
enhancer in the rat placental lactogen II gene that contains binding sites for
569
members of the Ets and AP-1 (activator protein 1) families of transcription
570
factors. Mol. Endocrinol. 13, 385-399
571
24. Orwig, K.E. and Soares, M.J. (1999) Transcriptional activation of the
572
decidual/trophoblast prolactin-related protein gene. Endocrinology 140, 4032-
573
4039
574
25. Peters, T.J., Chapman, B.M., Wolfe, M.W., and Soares, M.J. (2000) Placental
575
lactogen-I gene activation in differentiating trophoblast cells: extrinsic and
576
intrinsic regulation involving mitogen-activated protein kinase signaling pathways.
577
J. Endocrinol. 165, 443-456
28
578 579
26. Bischof, P., Truong, K., and Campana, A. (2003) Regulation of trophoblastic gelatinases by proto-oncogenes. Placenta 24, 155-163
580
27. Abell, A.N., Granger, D.A., Johnson, N.L., Vincent-Jordan, N., Dibble, C.F., and
581
Johnson, G.L. (2009) Trophoblast stem cell maintenance by fibroblast growth
582
factor 4 requires MEKK4 activation of Jun N-terminal kinase. Mol. Cell. Biol. 29,
583
2748-2761
584
28. Kashif, M., Hellwig, A., Hashemolhosseini, S., Kumar, V., Bock, F., Wang, H.,
585
Shahzad, K., Ranjan, S., Wolter, J., Madhusudhan, T., Bierhaus, A., Nawroth, P.,
586
and Isermann, B. (2012) Nuclear factor erythroid-derived 2 (Nfe2) regulates JunD
587
DNA-binding activity via acetylation: a novel mechanism regulating trophoblast
588
differentiation. J. Biol. Chem. 287, 5400-5411
589 590 591
29. Schorpp-Kistner, M., Wang, Z.Q., Angel, P., Wagner, E.F. (1999) JunB is essential for mammalian placentation. EMBO J. 18, 934-948 30. Schreiber, M., Wang, Z.Q., Jochum, W., Fetka, I., Elliott, C., and Wagner, E.F.
592
(2000) Placental vascularisation requires the AP-1 component fra1. Development
593
127, 4937-4948
594
31. Kent, L.N., Konno, T., and Soares, M.J. (2010) Phosphatidylinositol 3 kinase
595
modulation of trophoblast cell differentiation. BMC Dev. Biol. 10, 97
596
32. Faria, T.N. and Soares, M.J. (1991) Trophoblast cell differentiation:
597
establishment, characterization, and modulation of a rat trophoblast cell line
598
expressing members of the placental prolactin family. Endocrinology 129, 2895-
599
2906
29
600
33. Sahgal, N., Canham, L.N., Canham, B., and Soares, M.J. (2006) Rcho-1
601
trophoblast stem cells: a model system for studying trophoblast cell
602
differentiation. Methods Mol. Med. 121, 159-178
603
34. Asanoma, K., Rumi, M.A.K., Kent, L.N., Chakraborty, D., Renaud, S.J., Wake,
604
N., Lee, D.-S., Kubota, K., and Soares, M.J. (2011) FGF4-dependent stem cells
605
derived from rat blastocysts differentiate along the trophoblast lineage. Dev. Biol.
606
351, 110-119
607
35. Lee, D. S., Rumi, M. A., Konno, T., and Soares, M. J. (2009) In vivo genetic
608
manipulation of the rat trophoblast cell lineage using lentiviral vector delivery.
609
Genesis 47, 433-439
610
36. Roby, K.F., Larsen, D., Deb, S., and Soares, M.J. (1991) Generation and
611
characterization of antipeptide antibodies to rat cytochrome P-450 side-chain
612
cleavage enzyme. Mol. Cell. Endocrinol. 79, 13-20
613
37. Hamlin, G.P., Lu, X.J., Roby, K.F., and Soares, M.J. (1994) Recapitulation of the
614
pathway for trophoblast giant cell differentiation in vitro: stage-specific expression
615
of members of the prolactin gene family. Endocrinology 134, 2390-2396
616
38. Loots, G.G. and Ovcharenko, I. (2004) rVISTA 2.0: evolutionary analysis of
617 618
transcription factor binding sites. Nucleic Acids Res. 32, W217-W221 39. Peters, T.J., Albieri, A., Bevilacqua, E., Chapman, B.M., Crane, L.H., Hamlin,
619
G.P., Seiki, M., and Soares, M.J. (1999) Differentiation-dependent expression of
620
gelatinase B/matrix metalloproteinase-9 in trophoblast cells. Cell Tissue Res.
621
295, 287-296
30
622
40. Terranova, P.F. and Garza, F. (1983) Relationship between the preovulatory
623
luteinizing hormone (LH) surge and androstenedione synthesis of preantral
624
follicles in the cyclic hamster: detection by in vitro responses to LH. Biol. Reprod.
625
29, 630-636
626
41. Rampon, C., Prandini, M., Bouillot, S., Pointu, H., Tillet, E., Frank, R., Vernet,
627
M., and Huber, P. (2005) Protocadherin 12 (VE-cadherin 2) is expressed in
628
endothelial, trophoblast, and mesangial cells. Exp. Cell Res. 302, 48-60
629
42. Moussian, B. and Uv, A.E. (2005) An ancient control of epithelial barrier
630 631
formation and wound healing. BioEssays 27, 987-990 43. Wang, S. and Samakovlis, C. (2012) Grainy head and its target genes in
632
epithelial morphogenesis and wound healing. Current Topics Dev. Biol. 98, 35-
633
63
634
44. Henderson, Y.C., Frederick, M.J., Jayakumar, A., Choi, Y., Wang, M.T., Kang,
635
Y., Evans, R., Spring, P.M., Uesugi, M., and Clayman, G.L. (2007) Human LBP-
636
32/MGR is a repressor of the P450scc in human choriocarcinoma cell line JEG-3.
637
Placenta 28, 152-160
638
45. Henderson, Y.C., Frederick, M.J., Wang, M.T., Hollier, L.M., and Clayman, G.L.
639
(2008) LBP-1b, LBP-9, and LBP-32/MGR detected in syncytiotrophoblasts from
640
first-trimester human placental tissue and their transcriptional regulation. DNA
641
Cell Biol. 27, 71-79
642 643
46. Knöfler, M. (2010) Critical growth factors and signalling pathways controlling human trophoblast invasion. Int. J. Dev. Biol. 54, 269-280
31
644
47. Spencer, T.E. and Bazer, F.W. (2002) Biology of progesterone action during
645
pregnancy recognition and maintenance of pregnancy. Front. Biosci. 7, 1879-
646
1898
647
48. Librach, C.L., Werb, Z., Fitzgerald, M.L., Chiu, K., Corwin, N.M., Esteves, R.A.,
648
Grobelny, D., Galardy, R., Damsky, C.H., and Fisher, S.J. (1991) 92-kD type IV
649
collagenase mediates invasion of human cytotrophoblasts. J. Cell. Biol. 113, 437-
650
449
651
49. Plaks, V., Rinkenberger, J., Dai, J., Flannery, M., Sund, M., Kanasaki, K., Ni, W.,
652
Kalluri, R., and Werb, Z. (2013) Matrix metalloproteinase-9 deficiency
653
phenocopies features of preeclampsia and intrauterine growth restriction. Proc.
654
Natl. Acad. Sci. USA 110, 11109-11114
655 656 657
50. Miller, W.L. and Auchus, R.J. (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr. Rev. 32, 81-151 51. Escalante-Alcalde, D., Hernandez, L., Le Stunff, H., Maeda, R., Lee, H.S., Jr-
658
Gang-Cheng, Sciorra, V.A., Daar, I., Spiegel, S., Morris, A.J., and Stewart, C.L.
659
(2003) The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis
660
and axis patterning. Development 130, 4623-4637
661 662 663
52. Hilberg, F., Aguzzi, A., Howells, N., and Wagner, E.F. (1993) c-Jun is essential for normal mouse development and hepatogenesis. Nature 365, 179-181 53. Kashif, M., Hellwig, A., Hashemolhosseini, S., Kumar, V., Bock, F., Wang, H.,
664
Shahzad, K., Ranjan, S., Wolter, J., Madhusudhan, T., Bierhaus, A., Nawroth, P.,
665
and Isermann, B. (2012) Nuclear factor erythroid-derived 2 (Nfe2) regulates JunD
32
666
DNA-binding activity via acetylation: a novel mechanism regulating trophoblast
667
differentiation. J. Biol. Chem. 287, 5400-5411
668
54. Anson-Cartwright, L., Dawson, K., Holmyard, D., Fisher, S.J., Lazzarini, R.A.,
669
and Cross, J.C. (2000) The glial cells missing-1 protein is essential for branching
670
morphogenesis in the chorioallantoic placenta. Nat. Genet. 25, 311-314
671
55. Lu, J., Zhang, S., Nakano, H., Simmons, D.G., Wang, S., Kong, S., Wang, Q.,
672
Shen, L., Tu, Z., Wang, W., Wang, B., Wang, H., Wang, Y., van Es, J.H.,
673
Clevers, H., Leone, G., Cross, J.C., and Wang, H. (2013) A positive feedback
674
loop involving Gcm1 and Fzd5 directs chorionic branching morphogenesis in the
675
placenta. PLoS Biol. 11, e1001536
676
56. Reinke, A.W., Baek, J., Ashenberg, O., and Keating, A.E. (2013) Networks of
677
bZIP protein-protein interactions diversified over a billion years of evolution.
678
Science 340, 730-734
679 680 681
33
682
FIGURE LEGENDS
683
Fig. 1 FOSL1 regulation of the trophoblast cell phenotype. A) qRT-PCR analysis of
684
Fosl1, Prl3d1, Tpbpa, Prl5a1, Gcm1, and Pcdh12 expression in stem (Stem) and
685
differentiated (Diff) Rcho-1 TS cells. B) Western blot analysis of FOSL1 and GAPDH
686
expression in stem (Stem) and differentiated (Diff) Rcho-1 TS cells. FOSL knockdown
687
efficiency was validated by qRT-PCR (C) and western blot (D) analyses in differentiated
688
Rcho-1 TS cells expressing control (Ctrl) or Fosl1 shRNAs. GAPDH was used as an
689
internal control for the western blot analysis. E) FOSL1 localization and knockdown
690
efficiency were assessed by immunocytochemistry in stem and differentiated Rcho-1 TS
691
cells expressing Ctrl or Fosl1 shRNAs. FOSL1 was localized to nuclei (red). Cells were
692
counterstained for cytokeratin (CK, green) and/or DAPI (blue). Scale Bar = 100 μm. F)
693
DNA content was estimated by propidium iodine staining followed by flow cytometry. G)
694
qRT-PCR analysis of Prl3d1, Tpbpa, Prl5a1, Gcm1, and Pcdh12 transcripts in
695
differentiated Rcho-1 TS cells expressing Ctrl or Fosl1 shRNAs. H) Scatter plot of
696
microarray analysis shown as the natural logarithm of raw value signals for
697
differentiated Rcho-1 TS cells expressing Ctrl (x axis) or Fosl1 (y axis) shRNAs. The
698
magnitudes of fold changes (FC) are depicted by different colored dots. Bars from
699
histograms in panels A, C, and F represent the mean ± SEM. Values with an asterisk or
700
different characters indicates significantly difference (P